Results 161 to 170 of about 66,544 (280)

When to Choose In Vitro Fertilization (IVF) When Postponing Conceiving: The Age-Related Risk of IVF Failure at an Advanced Age. [PDF]

Obstet Gynecol Int
Chen Z, Zhang D, Sun Z, Yu Q, Zhao C, Li C.   +5 more
europepmc   +1 more source

When states require fully insured employers to cover in vitro fertilization (IVF), what do self-insured employers provide? [PDF]

J Assist Reprod Genet
Dupree JM, Kitaevich J, Agostino C, Murali S, Borah L, Castle SK, Kirkland A.   +6 more
europepmc   +1 more source

Normative range for MRI amniotic fluid volume from 16 to 36 gestational weeks: Absolute and relative values, and correlation to ultrasound

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 878-886, May 2026.
This study provides the first MRI‐based normative reference charts for amniotic fluid volume (AFV) and the AFV‐to‐fetal body volume ratio from 16 to 36 weeks' gestation. AFV peaks at 30–31 weeks. These charts offer a reproducible standard for research and complex clinical scenarios.
Amine Bouachba, Julie Chabourlin, David Grévent, Joana De Jesus Neves, Laurence Bussières, Sunniva Vaillant, Laurent Julien Salomon, Guillaume Gorincour   +7 more
wiley   +1 more source

Differences in Maternal and Neonatal Outcomes Between Pregnancies Following Intrauterine Insemination (IUI) and In Vitro Fertilization (IVF): A Review. [PDF]

J Clin Med
Cherouveim P, Cetin E, Tuli S, Lombard T, Youssef Y, Moawad G, Ayoubi JM, Feki A.   +7 more
europepmc   +1 more source

Fertility Governance Through Cascaded Accountability: Building Inclusive Safety Nets for Vulnerable Workers

Gender, Work &Organization, Volume 33, Issue 3, Page 919-930, May 2026.
ABSTRACT This article examines how workplace fertility governance operates as a system of control, consent, and inequality shaped by organizational, cultural, and institutional forces. Drawing on feminist theory, we develop a multilevel framework of cascading accountability that integrates symbolic violence, biopolitics, chrononormativity, and ...
Meltem Yavuz Serçekman, Mustafa F. Özbilgin   +1 more
wiley   +1 more source

Navigating health insurance selection for in vitro fertilization (IVF) benefits: A study protocol. [PDF]

Contemp Clin Trials
Dayo O, Turcotte V, Reyes B, Flores Ortega RE, Kaiser BN, Aarons GA, McMenamin SB, Su HI, Romero SAD.   +8 more
europepmc   +1 more source

Generation of Cloned Sheep Lacking Galactose‐α1,3‐Galactose and N‐Glycolylneuraminic Acid Antigens

Xenotransplantation, Volume 33, Issue 3, May/June 2026.
ABSTRACT Livestock have long been regarded as a potential source of donor organs to alleviate the global organ shortage for transplantation. Sheep have a similar anatomy to humans, providing the standard model for demonstrating biocompatibility and performance of biological heart valves to obtain regulatory approval for their use in transplantation ...
Sarah J. Appleby, Lisanne M. Fermin, Zachariah L. McLean, Stephanie Delaney, Stefan Wagner, Cecilia Di Genova, Jingwei Wei, Fanli Meng, David N. Wells, Björn Oback   +9 more
wiley   +1 more source

Fertility preservation and in vitro fertilization (IVF) success rates after cancer. [PDF]

JNCI Cancer Spectr
Anderson C, Wardell AC, Deal AM, Mersereau JE, Cameron K, Spandorfer SD, Baker VL, Mitra S, Cai J, Luke B, Nichols HB.   +10 more
europepmc   +1 more source

Innate Immunity and Microbial Recognition in Reproduction: From Barrier Defense to Maternal–Fetal Tolerance

The FASEB Journal, Volume 40, Issue 8, 30 April 2026.
Graphical abstract illustrating the barrier defense–tolerance framework of reproductive innate immunity. Across the female and male reproductive tracts and the maternal–fetal interface, epithelial barriers, innate sensors, immune cells, and microbial signals are integrated to preserve reproductive homeostasis.
Xianlin Rao, Li Zou, Yao Yao, Changling Liu   +3 more
wiley   +1 more source

Thymoquinone alleviates the adverse effects of cyclophosphamide on oogenesis and in vitro fertilization (IVF) in NMRI mice. [PDF]

Avicenna J Phytomed
Etebari S, Rouki V, Asouri M, Nasirikenari M, Meshkani SE, Momtaz MR, Amoueian S, Babaki Y, Hajati F, Ahmadi AA.   +9 more
europepmc   +1 more source